In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disease and is characterized by the formation of renal cysts and the eventual development of end-stage kidney disease. One approach to treating ADPKD is through inhibition of the mammalian target of rapamycin (mTO...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Alysia, Tung, Madelynn, Li, Hui, Hallows, Kenneth R., Chung, Eun Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439257/
https://www.ncbi.nlm.nih.gov/pubmed/36804177
http://dx.doi.org/10.1016/j.slast.2023.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439257/
https://www.ncbi.nlm.nih.gov/pubmed/36804177
http://dx.doi.org/10.1016/j.slast.2023.02.001

Ejemplares similares